Regulation of Proinflammatory Signaling Pathways in CFTR
CFTR 中促炎信号通路的调节
基本信息
- 批准号:7477883
- 负责人:
- 金额:$ 29.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-06-15 至 2011-08-14
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAntibodiesBindingBinding ProteinsBiologyBiopsyCell DeathCell LineCell NucleusCellsChemicalsChemistryChronicComplexCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDNADNA SequenceDataDiseaseDoctor of MedicineDoctor of PhilosophyEpithelial CellsEpitheliumEthanolFormaldehydeFreezingGelshift AnalysisGene TransferGenesGlandGoalsHeatingHeterogeneous-Nuclear RibonucleoproteinsIL8 geneIn VitroIndividualInfectionInflammatoryInformatinInvestigationLaboratoriesLengthLifeLocationLungMapsMass Spectrum AnalysisMethodsMicroarray AnalysisMicrodissectionMolecularMutateMutationNF-kappa BNuclear ExtractNuclear ProteinNuclear ProteinsObstructionPhenotypePropertyProtein BindingProtein MicrochipsProteinsProteomicsRadiolabeledRecoveryRegulationResearch PersonnelRespiratory physiologySamplingSignal PathwaySignal TransductionStructure of parenchyma of lungSurfaceSystemTechnologyTestingTissuesairway inflammationaqueousbasecis acting elementcrosslinkcystic fibrosis patientsdisorder controlexperiencehnRNP A1in vivoinnovationlink proteinmutantprogramspromoterprotein functionradiotracerreconstitutionrepaired
项目摘要
DESCRIPTION (provided by applicant): Cystic fibrosis (CF) is the most common fatal autosomal recessive disease in the U.S., and is due to mutations in the CFTR gene. CF is characterized by constitutive hypersecretion of proinflammatory IL-8 from airway epithelial cells, and death usually ensues from chronic airway inflammation and loss of lung function. Our long term goal has therefore been to identify the mechanisms by which CFTR mutations cause constitutive IL-8 secretion from CF lung epithelial cells. Our approach is to identify the proteins which bind to the IL-8 promoter in CF lung epithelial cells, and to determine which one(s) might be responsible for the hyper-productive IL-8 phenotype. Preliminary data show that NFkappaB signaling is critical for IL-8 promoter activity in CF cells. In addition, we find that the protein hnRNP[A2B1] binds to the IL-8 promoter, affects NFkappaB action, and further activates IL-8 expression in CF cells. Based on these and other preliminary data we have hypothesized that hnRNP[A2B1], and possibly other proteins binding to the IL-8 promoter, are responsible for regulating constitutive, NFkappaB-dependent hyperexpression of IL-8 in CF lung epithelial cells. To test this hypothesis in vitro and in vivo, we propose the following specific aims: Specific Aim1: To identify proteins which bind to the IL-8 promoter in CF lung epithelial cells, and to determine their mechanisms of action on IL-8 expression. We will use mass spectrometry and crosslinking studies to identify and chemically validate proteins in nuclear extracts of CF lung epithelial cells which bind to the 167 bp IL-8 promoter DNA. Specific Aim 2: To map the locations and determine the molecular mechanism of interaction for proteins binding to the IL-8 promoter in CF lung epithelial cells. We will test the ability of free wildtype and mutant IL-8 promoter DNA sequences to competitively displace proteins from immobilized IL-8 promoter DNA. Specific Aim 3: To investigate the ensemble of proteins associated with the IL-8 promoter in bronchial lung epithelial cells from CF patients. We will prepare nuclear extracts from expanded cultures of CF and non-CF disease control bronchial brush biopsies of CF patients, and determine the proteins which bind to the IL-8 DNA promoter sequence. Significance, innovation, and uniqueness: This proposal is significant in that successful completion will determine those dysfunctional signaling pathway proteins which are responsible, directly or indirectly, for the proinflammatory lung phenotype of CF. The proposal is both unique and innovative by directing the investigation to the biology and chemistry of the IL-8 promoter in CF lung epithelial cells, both in vitro and in vivo.
描述(由申请人提供):囊性纤维化 (CF) 是美国最常见的致命性常染色体隐性遗传疾病,由 CFTR 基因突变引起。 CF 的特征是气道上皮细胞促炎性 IL-8 的组成性过度分泌,慢性气道炎症和肺功能丧失通常会导致死亡。因此,我们的长期目标是确定 CFTR 突变导致 CF 肺上皮细胞组成型 IL-8 分泌的机制。我们的方法是鉴定 CF 肺上皮细胞中与 IL-8 启动子结合的蛋白质,并确定哪些蛋白质可能导致 IL-8 高产表型。初步数据表明,NFkappaB 信号传导对于 CF 细胞中 IL-8 启动子活性至关重要。此外,我们发现蛋白质hnRNP[A2B1]与IL-8启动子结合,影响NFkappaB的作用,并进一步激活CF细胞中IL-8的表达。基于这些和其他初步数据,我们假设 hnRNP[A2B1] 以及可能与 IL-8 启动子结合的其他蛋白质负责调节 CF 肺上皮细胞中 IL-8 的组成型、NFκB 依赖性超表达。为了在体外和体内检验这一假设,我们提出以下具体目标: 具体目标1:鉴定CF肺上皮细胞中与IL-8启动子结合的蛋白质,并确定其对IL-8表达的作用机制。我们将使用质谱和交联研究来鉴定和化学验证 CF 肺上皮细胞核提取物中与 167 bp IL-8 启动子 DNA 结合的蛋白质。具体目标 2:绘制 CF 肺上皮细胞中与 IL-8 启动子结合的蛋白质的位置图并确定相互作用的分子机制。我们将测试游离野生型和突变型 IL-8 启动子 DNA 序列竞争性取代固定化 IL-8 启动子 DNA 中的蛋白质的能力。具体目标 3:研究 CF 患者支气管肺上皮细胞中与 IL-8 启动子相关的蛋白质集合。我们将从 CF 患者的 CF 和非 CF 疾病控制支气管刷活检的扩大培养物中制备核提取物,并确定与 IL-8 DNA 启动子序列结合的蛋白质。意义、创新性和独特性:该提案具有重要意义,因为成功完成将确定那些直接或间接导致 CF 促炎性肺表型的功能失调的信号通路蛋白。该提案通过在体外和体内研究 CF 肺上皮细胞中 IL-8 启动子的生物学和化学特性,既独特又具有创新性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harvey Bruce Pollard其他文献
Harvey Bruce Pollard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Harvey Bruce Pollard', 18)}}的其他基金
COVID-19 airway inflammation is due to Spike inhibition of CFTR signaling
COVID-19 气道炎症是由于 CFTR 信号的 Spike 抑制所致
- 批准号:
10566710 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Regulation of Proinflammatory Signaling Pathways by CFTR
CFTR 对促炎信号通路的调节
- 批准号:
6433785 - 财政年份:1998
- 资助金额:
$ 29.52万 - 项目类别:
Regulation of Proinflammatory Signaling Pathways in CFTR
CFTR 中促炎信号通路的调节
- 批准号:
7143989 - 财政年份:1998
- 资助金额:
$ 29.52万 - 项目类别:
Regulation of Proinflammatory Signaling Pathways in CFTR
CFTR 中促炎信号通路的调节
- 批准号:
7275391 - 财政年份:1998
- 资助金额:
$ 29.52万 - 项目类别:
PHOSPHOLIPIDS AS CHEMICAL CHAPERONES FOR CFTR
磷脂作为 CFTR 的化学伴侣
- 批准号:
2628917 - 财政年份:1998
- 资助金额:
$ 29.52万 - 项目类别:
Regulation of Proinflammatory Signaling Pathways by CFTR
CFTR 对促炎信号通路的调节
- 批准号:
6704704 - 财政年份:1998
- 资助金额:
$ 29.52万 - 项目类别:
Regulation of Proinflammatory Signaling Pathways in CFTR
CFTR 中促炎信号通路的调节
- 批准号:
7671433 - 财政年份:1998
- 资助金额:
$ 29.52万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
中国年轻女性接种不同剂次国产双价HPV16/18疫苗的特异性抗体亲和力及细胞免疫反应研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于酵母展示与自体持续突变的纳米抗体快速亲和力成熟技术研究
- 批准号:82204046
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于新抗原受体可变域的赭曲霉毒素A竞争物与VHH抗体互作的亲和力调控机制
- 批准号:32102067
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Bioorthogonal probe development for highly parallel in vivo imaging
用于高度并行体内成像的生物正交探针开发
- 批准号:
10596786 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 29.52万 - 项目类别: